ALC:NYSE
Alcon AG
75,26Â US$
arrow_upward
+1,55%(+1,15) 1K
74,27Â US$
arrow_downward
-1,32% (-0,99)todayBirjadan oldin
Savdolar yopilgan: 18-noy, 16:00:03 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALC tikeri uchun statistika yaratilmoqda...
Ochish
73,41Â US$
Yuqori
75,52Â US$
Past
73,34Â US$
Bozor kapitali
31,34Â mlrd
Oʻrtacha hajm
2,23Â mln
Hajmi
7,42Â ming
52 haftalik eng yuqori
87,64Â US$
52 haftalik eng past
61,84Â US$
Beta
0,87
Muomaladagi aksiyalar
480,40Â mln
Xodimlar soni
25Â ming
Ochish
73,41Â US$
Yuqori
75,52Â US$
Past
73,34Â US$
Bozor kapitali
31,34Â mlrd
Oʻrtacha hajm
2,23Â mln
Hajmi
7,42Â ming
52 haftalik eng yuqori
87,64Â US$
52 haftalik eng past
61,84Â US$
Beta
0,87
Muomaladagi aksiyalar
480,40Â mln
Xodimlar soni
25Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Zacks
·
23 soat oldin
What Drove Glaukos Stock's 48% Rally Since the End of September?
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25Â ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
SektorHealth Care
Soha-
Veb-saytalcon.com